Bobb Jennifer F, Lee Amy K, Lapham Gwen T, Oliver Malia, Ludman Evette, Achtmeyer Carol, Parrish Rebecca, Caldeiro Ryan M, Lozano Paula, Richards Julie E, Bradley Katharine A
Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave, Ste 1600, Seattle, WA 98101, USA.
Center of Excellence in Substance Abuse Treatment and Education, VA Puget Sound Health Care System 1660 S. Columbian Way, Seattle, WA 98108, USA.
Int J Environ Res Public Health. 2017 Sep 8;14(9):1030. doi: 10.3390/ijerph14091030.
Alcohol use is a major cause of disability and death worldwide. To improve prevention and treatment addressing unhealthy alcohol use, experts recommend that alcohol-related care be integrated into primary care (PC). However, few healthcare systems do so. To address this gap, implementation researchers and clinical leaders at Kaiser Permanente Washington partnered to design a high-quality Program of Sustained Patient-centered Alcohol-related Care (SPARC). Here, we describe the SPARC pilot implementation, evaluate its effectiveness within three large pilot sites, and describe the qualitative findings on barriers and facilitators. Across the three sites ( = 74,225 PC patients), alcohol screening increased from 8.9% of patients pre-implementation to 62% post-implementation ( < 0.0001), with a corresponding increase in assessment for alcohol use disorders (AUD) from 1.2 to 75 patients per 10,000 seen ( < 0.0001). Increases were sustained over a year later, with screening at 84.5% and an assessment rate of 81 patients per 10,000 seen across all sites. In addition, there was a 50% increase in the number of new AUD diagnoses ( = 0.0002), and a non-statistically significant 54% increase in treatment within 14 days of new diagnoses ( = 0.083). The pilot informed an ongoing stepped-wedge trial in the remaining 22 PC sites.
在全球范围内,饮酒是导致残疾和死亡的主要原因。为了改进针对不健康饮酒行为的预防和治疗措施,专家建议将与酒精相关的护理纳入初级保健(PC)。然而,很少有医疗保健系统这样做。为了填补这一空白,华盛顿凯撒医疗集团的实施研究人员和临床负责人合作设计了一项高质量的以患者为中心的持续性酒精相关护理计划(SPARC)。在此,我们描述SPARC试点实施情况,评估其在三个大型试点地点的有效性,并描述关于障碍和促进因素的定性研究结果。在这三个地点(共74,225名初级保健患者),酒精筛查从实施前的8.9%的患者增加到实施后的62%(P<0.0001),每10,000名就诊患者中酒精使用障碍(AUD)的评估人数相应从1.2人增加到75人(P<0.0001)。一年多后,这些增加的比例仍持续存在,所有地点的筛查率为84.5%,每10,000名就诊患者的评估率为81人。此外,新的酒精使用障碍诊断数量增加了50%(P = 0.0002),新诊断后14天内的治疗人数增加了54%,但无统计学意义(P = 0.083)。该试点为其余22个初级保健地点正在进行的阶梯式楔形试验提供了参考。